New Vaccine for the UK

Spread the love

New Vaccine for the UK

U.K. First To Approve Omicron Vaccine (3 min)

Lucky buggers in UK they are the first to get a new vaccine rolled out! (lolz).   The vaccine consists of 50% vaccine for the original virus Wuhan wild strain that no longer exists and 50% vaccine for the BA1  strain which months ago consisted of only 0.7% of all the variants (lolz).  And what is that utter nonsense about antibody titers???  (JC should have a field day).

Nurse Campbell promotes the big lie of 14.4 million people saved from Covid deaths by vaccines. We know this is a lie. Here from the article itself:

"The impact of COVID-19 vaccination programmes was determined by estimating the additional lives lost if no vaccines had been distributed. We also estimated the additional deaths that would have been averted had the vaccination coverage targets of 20% set by COVAX and 40% set by WHO been achieved by the end of 2021".

This is the “rigorous” methodology and modelling practiced by Neil Ferguson between getting his leg over committing adultery while everyone else was locked down (lolz). We know the Lancet is corrupt and captured. We know what they did and the narrative that they promoted. I am good at guessing, can I become a virologist?

The vaccinations did nothing to stop transmission and neither will these. All they did was increase the risk for neurotropic disease,  coagulopathy and autoimmunity. The long term consequences of these experiments with transfections are already proving to be horrific. As far as I am concerned Moderna can shove their vaxx where the sun don’t shine.  They killed people.  In 2017 Moderna registered the patent for MHS3 homolog which included  the furin- cleavage site (FCS). I thought the FCS escaped from nature (even though they never found the host).  No one should ever take anything from these monsters and no one should listen to the Lancet who ran cover for these crooked pharma companies.   

New covid vaccine for UK 20 min

Bivalent new vaccine, Moderna press release… Omicron-containing bivalent COVID booster candidate, mRNA-1273.214 (original mRNA-1273 vaccine), Superior neutralizing antibody response in baseline seronegative participants. increased neutralizing geometric mean titers (GMT) against Omicron approximately 8-fold above baseline levels. mRNA-1273.214 50 μg booster dose, well-tolerated in the 437 study participants The safety and reactogenicity profile of the mRNA-1273.214 50 μg booster dose was similar to that of mRNA-1273 50 μg BA.1 SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 44… BA.2 3.4% BA.4 17.2% BA.5 78.7% Other 0.7% US variants… BA.5 88.8% BA.4 5.3% BA.4.6 5.1% BA.2.12.1 0.8% BA.2 0% BA.1s 0% Delta 0% Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada… Population-based cohort study of 297 individuals in Ontario, Canada, with myocarditis or pericarditis following COVID-19 vaccination, found higher rates of myocarditis or pericarditis associated with receipt of mRNA-1273 compared with BNT162b2 as a second dose, particularly among male individuals aged 18 to 24 years. The results suggest that there may be product-specific differences in rates of myocarditis or pericarditis after receiving mRNA vaccines First bivalent COVID-19 booster vaccine approved by UK medicines regulator… Moderna bivalent approved for adult booster doses by MHRA Spikevax bivalent Original/Omicron 25 micrograms targets the original virus strain 25 micrograms targets Omicron Omicron (BA.1) and the original 2020 strain (was also found to generate a good immune response against BA.4 and BA.5) Safety monitoring side effects observed were the same as those seen for the original Moderna booster dose, and were typically mild and self-resolving, and no serious safety concerns were identified. Global covid deaths… 6,466,947 Evidence cited by HMRA… Based on official reported COVID-19 deaths, we estimated that vaccinations prevented 14·4 million deaths from COVID-19 in 185 countries, between Dec 8, 2020, and Dec 8, 2021. 19·8 million when we used excess deaths as an estimate Joint Committee on Vaccination and Immunisation (JCVI) updated statement on the COVID-19 vaccination programme for autumn 2022 For autumn 2022… JCVI advises the following groups should be offered a COVID-19 booster vaccine: residents in a care home for older adults and staff working in care homes for older adults frontline health and social care workers all adults aged 50 years and over persons aged 5 to 49 years in a clinical risk group persons aged 5 to 49 years who are household contacts of people with immunosuppression persons aged 16 to 49 years who are carers Time to collect PROSPECTIVE data Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents… Thai adolescents, 13 to 18, both sexes Cardiovascular effects Found in 29.24% of patients, Most common cardiovascular effects Tachycardia, 7.64% Shortness of breath, 6.64% Palpitation, 4.32% Chest pain, 4.32% Hypertension, 3.99% Abnormal ECG finding, 54 patients (17.94%) Seven participants (2.33%) (all male) At least one elevated cardiac biomarker or positive lab assessments